0001365618-12-000004.txt : 20120913
0001365618-12-000004.hdr.sgml : 20120913
20120913182212
ACCESSION NUMBER: 0001365618-12-000004
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120911
FILED AS OF DATE: 20120913
DATE AS OF CHANGE: 20120913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hove Anders D
CENTRAL INDEX KEY: 0001365618
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34973
FILM NUMBER: 121090989
MAIL ADDRESS:
STREET 1: 30 ROCKEFELLER PLAZA, SUITE 5508
CITY: NEW YORK
STATE: NY
ZIP: 10112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anacor Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001411158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 251854385
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
BUSINESS PHONE: 650-543-7500
MAIL ADDRESS:
STREET 1: 1020 E. MEADOW CIRCLE
CITY: PALO ALTO
STATE: CA
ZIP: 94303
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2012-09-11
0001411158
Anacor Pharmaceuticals Inc
ANAC
0001365618
Hove Anders D
C/O VENROCK
3340 HILLVIEW AVE.
PALO ALTO
CA
94304
1
0
1
0
Common Stock
2012-09-11
4
S
0
10177
6.6427
D
3794808
I
By Funds and LLC's
Common Stock
2012-09-13
4
S
0
15000
6.5553
D
3779808
I
By Funds and LLC's
Consists of 1,721,350 shares held by Venrock Associates IV, L.P. ("VA4"), 351,036 shares held by Venrock Partners, L.P. ("VP"), 42,293 shares held by Venrock Entrepreneurs Fund IV, L.P. ("VEF4"), 1,361,755 shares held by Venrock Healthcare Capital Partners, L.P. ("VHCP"), 249,101 shares held by VHCP Co-Investment Holdings LLC ("VHCP Co-Invest"), 46,092 shares held by Venrock Associates V, L.P. ("VA5"), 3,908 shares held by Venrock Partners V, L.P. ("VP5"), 5,663 shares held by Venrock Management IV, LLC ("VM4"), 1,193 shares held by Venrock Partners Management, LLC ("VPM"), 82 shares held by VEF Managment IV, LLC ("VEFM4") and 12,335 shares held by VHCP Management, LLC ("VHCP Management").
VM4, VPM, VEFM4 are the sole general partners of VA4, VP and VEF4, respectively, and may be deemed to beneficially own these shares. VHCP Management is the general partner of VHCP and the manager of VHCP Co-Invest and may be deemed to beneficially own these shares. Venrock Management V, LLC ("VM5") and Venrock Partners Management V, LLC ("VPM5") are the sole general partners of VA5 and VP5, respectively, and may be deemed to beneficially own these shares. Anders Hove is a member of VM4, VPM, VEFM4, VM5 and VPM5 and a managing member of VHCP Management. Dr. Hove expressly disclaims beneficial ownership over all shares held by VA4, VP, VEF4, VA5, VP5, VHCP, VHCP Co-Invest, VM4, VPM, VEFM4, VM5, VPM5 and VHCP Management except to the extent of his indirect pecuniary interest therein.
Consists of 1,721,350 shares held by VA4, 351,036 shares held by VP, 42,293 shares held by VEF4, 1,361,755 shares held by VHCP, 249,101 shares held by VHCP Co-Invest, 32,265 shares held by VA5, 2,735 shares held by VP5, 5,663 shares held by VM4, 1,193 shares held by VPM, 82 shares held by VEFM4 and 12,335 shares held by VHCP Management.
/s/ Anders D. Hove
2012-09-13